Literature DB >> 11030606

Cytokines and acute pancreatitis.

M Brady1, S Christmas, R Sutton, J Neoptolemos, J Slavin.   

Abstract

Cytokines have been shown to play a pivotal role in multiple organ dysfunction, a major cause of death in severe acute pancreatitis. Moreover, the two-hit hypothesis of the cytokine-induced systemic inflammatory response syndrome explains the variable individual response to severe acute pancreatitis and the impact of secondary events such as sepsis or therapeutic intervention. Many experimental anti-cytokine therapies have been administered following induction of experimental pancreatitis, and have proved to be therapeutic. Patients with severe pancreatitis present early because of pain. Clearly then a window for therapeutic intervention is available between onset of symptoms and peak pro-inflammatory cytokine expression. It is this fundamental observation that convinces many in the field that the treatment of AP will be one of the first clinical successes for novel drugs or therapy that seek to modulate the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11030606     DOI: 10.1053/bega.1999.0024

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Gastroenterol


  20 in total

Review 1.  Lexipafant in severe acute pancreatitis: the final word?

Authors:  C D Ulrich
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 2.  Severe hypophosphatemia associated with gallstone pancreatitis: a case report and review of the literature.

Authors:  David A Steckman; Jenifer L Marks; Mike K Liang
Journal:  Dig Dis Sci       Date:  2006-04-27       Impact factor: 3.199

3.  Experimental study of therapeutic efficacy of Baicalin in rats with severe acute pancreatitis.

Authors:  Xi-Ping Zhang; Ling Zhang; Jin-Xian He; Rui-Ping Zhang; Qi-Hu Cheng; Yi-Feng Zhou; Bei Lu
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

4.  Changes of neuronal acetylcholine receptor alpha 7 of peritoneal macrophage in experimental acute pancreatitis treated by Chaiqin Chengqi Decoction ().

Authors:  Ping Xue; Jia Guo; Xiao-nan Yang; Wei Huang; Qing Xia
Journal:  Chin J Integr Med       Date:  2014-01-23       Impact factor: 1.978

5.  CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications.

Authors:  Bettina Rau; Katja Baumgart; Colin M Krüger; Martin Schilling; Hans G Beger
Journal:  Intensive Care Med       Date:  2003-02-15       Impact factor: 17.440

6.  Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice.

Authors:  David J van Westerloo; Sandrine Florquin; Anita M de Boer; Joost Daalhuisen; Alex F de Vos; Marco J Bruno; Tom van der Poll
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  Tumor necrosis factor alpha antibody prevents brain damage of rats with acute necrotizing pancreatitis.

Authors:  Yan-Ling Yang; Ji-Peng Li; Kai-Zong Li; Ke-Feng Dou
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

Review 8.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

9.  Effect of 5-FU on modulation of disarrangement of immune-associated cytokines in experimental acute pancreatitis.

Authors:  Xiao-Li Chen; Sang-Zhu Ciren; Hui Zhang; Li-Geng Duan; Alexander J Wesley
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

10.  Clinical effects of laparotomy with perioperative continuous peritoneal lavage and postoperative hemofiltration in patients with severe acute pancreatitis.

Authors:  Roberto Caronna; Michele Benedetti; Andrea Morelli; Monica Rocco; Loretta Diana; Giampaolo Prezioso; Maurizio Cardi; Monica Schiratti; Gabriele Martino; Gianfranco Fanello; Federica Papini; Francesco Farelli; Roberto L Meniconi; Michele Marengo; Giuseppe Dinatale; Piero Chirletti
Journal:  World J Emerg Surg       Date:  2009-12-16       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.